Leslie D. Funtleyder - 20 Nov 2023 Form 4 Insider Report for Applied Therapeutics Inc. (APLT)

Role: Chief Financial Officer, Director
Signature: /s/ Shoshana Shendelman, as attorney-in-fact
Issuer symbol: APLT
Transactions as of: 20 Nov 2023
Net transactions value: $0
Form type: 4
Filing time: 20 Nov 2023, 16:41:38 UTC
Previous filing: 14 Nov 2023
Next filing: 18 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	APLT	Common Stock	Award	$0	+300,000	+808%	$0.000000	337,148	20 Nov 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of compensatory Restricted Stock Units granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan in connection with the Reporting Person's appointment as Chief Financial Officer. Each compensatory Restricted Stock Unit represents a contingent right to receive one share of the issuer's common stock. The compensatory Restricted Stock Units shall vest in equal monthly installments over the two-year period following the date of grant, subject to the Reporting Person continuing to provide services through each such vesting date.

Content

Consists of compensatory Restricted Stock Units granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan in connection with the Reporting Person's appointment as Chief Financial Officer. Each compensatory Restricted Stock Unit represents a contingent right to receive one share of the issuer's common stock. The compensatory Restricted Stock Units shall vest in equal monthly installments over the two-year period following the date of grant, subject to the Reporting Person continuing to provide services through each such vesting date.